You are here

  • Home
  • Archive
  • Volume 74, Issue Suppl 2
  • THU0234 Long-Term Efficacy of Infliximab in Patients with Ankylosing Spondylitis – Real Life Data Confirm the Potential for Dose Reduction by Stretching Infusion Intervals

Citation Tools

Article menu

Download PDFPDF

Poster Presentations
Spondyloarthritis - treatment
THU0234 Long-Term Efficacy of Infliximab in Patients with Ankylosing Spondylitis – Real Life Data Confirm the Potential for Dose Reduction by Stretching Infusion Intervals

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Baraliakos X, Heldmann F, van den Bosch F, et al
THU0234 Long-Term Efficacy of Infliximab in Patients with Ankylosing Spondylitis – Real Life Data Confirm the Potential for Dose Reduction by Stretching Infusion Intervals
Annals of the Rheumatic Diseases 2015;74:281.